Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torben F Orntoft

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Cancer Research|August 18, 2004
Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulationJosefina Martinez Hoyos, Monica Fedele, Sabrina Battista, et al.
Comparative and Functional Genomics|July 17, 2008
Identification of a core set of genes that signifies pathways underlying cardiac hypertrophyClaes C Strøm, Mogens Kruhøffer, Steen Knudsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
A molecular signature in superficial bladder carcinoma predicts clinical outcomeLars Dyrskjøt, Karsten Zieger, Mogens Kruhøffer, et al.
Cancer Research|January 25, 2005
High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumorsKaren Koed, Carsten Wiuf, Lise-Lotte Christensen, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 1, 2008
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancerFrancisco Mansilla, Kerry-Ann da Costa, Shuli Wang, et al.
BMC Cancer|April 15, 2011
Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancerIver Nordentoft, Lars Dyrskjøt, Julie S Bødker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methodsMing-Lan Lu, Friedrik Wikman, Torben F Orntoft, et al.
Blood|February 15, 2003
The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarraysLaurent Vallat, Henri Magdelénat, Helene Merle-Béral, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2011
Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markersThomas Reinert, Charlotte Modin, Francisco M Castano, et al.
The Journal of Urology|December 4, 2012
Combinations of urinary biomarkers for surveillance of patients with incident nonmuscle invasive bladder cancer: the European FP7 UROMOL projectTahlita C M Zuiverloon, Willemien Beukers, Kirstin A van der Keur, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Cancer Research|August 18, 2004
Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulationJosefina Martinez Hoyos, Monica Fedele, Sabrina Battista, et al.
Comparative and Functional Genomics|July 17, 2008
Identification of a core set of genes that signifies pathways underlying cardiac hypertrophyClaes C Strøm, Mogens Kruhøffer, Steen Knudsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
A molecular signature in superficial bladder carcinoma predicts clinical outcomeLars Dyrskjøt, Karsten Zieger, Mogens Kruhøffer, et al.
Cancer Research|January 25, 2005
High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumorsKaren Koed, Carsten Wiuf, Lise-Lotte Christensen, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 1, 2008
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancerFrancisco Mansilla, Kerry-Ann da Costa, Shuli Wang, et al.
BMC Cancer|April 15, 2011
Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancerIver Nordentoft, Lars Dyrskjøt, Julie S Bødker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methodsMing-Lan Lu, Friedrik Wikman, Torben F Orntoft, et al.
Blood|February 15, 2003
The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarraysLaurent Vallat, Henri Magdelénat, Helene Merle-Béral, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2011
Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markersThomas Reinert, Charlotte Modin, Francisco M Castano, et al.
The Journal of Urology|December 4, 2012
Combinations of urinary biomarkers for surveillance of patients with incident nonmuscle invasive bladder cancer: the European FP7 UROMOL projectTahlita C M Zuiverloon, Willemien Beukers, Kirstin A van der Keur, et al.
Pageof 7